Results 341 to 350 of about 576,280 (398)
Some of the next articles are maybe not open access.
Atopic dermatitis: an expanding therapeutic pipeline for a complex disease
Atopic dermatitis (AD) is a common chronic inflammatory skin disease with a complex pathophysiology that underlies a wide spectrum of clinical phenotypes. AD remains challenging to treat owing to the limited response to available therapies.
Thomas Bieber
exaly +2 more sources
North American Contact Dermatitis Group Patch Test Results: 2019–2020
Dermatitis, 2023: Background: Patch testing is an important diagnostic tool for assessment of allergic contact dermatitis (ACD). Objective: This study documents the North American Contact Dermatitis Group (NACDG) patch testing results from January 1, 2019, to ...
J. DeKoven +17 more
semanticscholar +1 more source
Emergency Medicine Clinics of North America, 1985
Dermatitis, the inflammatory response of the skin to various factors, may present in a variety of forms. Atopic dermatitis, contact dermatitis, nummular eczema, seborrhea, and stasis dermatitis, conditions with which the patient may present to the emergency department, either in the acute stage or with exacerbation of a chronic condition, are reviewed ...
G, Sternbach, J P, Callen
openaire +2 more sources
Dermatitis, the inflammatory response of the skin to various factors, may present in a variety of forms. Atopic dermatitis, contact dermatitis, nummular eczema, seborrhea, and stasis dermatitis, conditions with which the patient may present to the emergency department, either in the acute stage or with exacerbation of a chronic condition, are reviewed ...
G, Sternbach, J P, Callen
openaire +2 more sources
North American Contact Dermatitis Group Patch Test Results: 2017–2018
Dermatitis, 2021Background Patch testing is an important diagnostic tool for assessment of allergic contact dermatitis (ACD). Objective This study documented the North American Contact Dermatitis Group (NACDG) patch testing results from March 1, 2017, to December 31 ...
J. DeKoven +13 more
semanticscholar +1 more source
British Journal of Dermatology, 2020
Baricitinib, an oral selective Janus kinase 1 and 2 inhibitor, effectively reduced atopic dermatitis (AD) severity in a phase II study with concomitant topical corticosteroids.
E. Simpson +23 more
semanticscholar +1 more source
Baricitinib, an oral selective Janus kinase 1 and 2 inhibitor, effectively reduced atopic dermatitis (AD) severity in a phase II study with concomitant topical corticosteroids.
E. Simpson +23 more
semanticscholar +1 more source
Contact Dermatitis, 1986
32 ethylenediamine‐sensitive patients were studied to determine cross‐sensitivity reactions. Reaction to other aliphatic polyamines proved to be very high, whereas no significant result was obtained to antihistamines, cither topically or orally.
BALATO, NICOLA +3 more
openaire +3 more sources
32 ethylenediamine‐sensitive patients were studied to determine cross‐sensitivity reactions. Reaction to other aliphatic polyamines proved to be very high, whereas no significant result was obtained to antihistamines, cither topically or orally.
BALATO, NICOLA +3 more
openaire +3 more sources
The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis
Nature Immunology, 2018Teruki Dainichi +2 more
exaly +2 more sources

